2-cyclohexyl-10-phenyl-1,9,10,10a-tetrahydropyrrolo[3,4-b][1,5]benzodiazepin-3(2H)-one (7468-51-1)

Identification
Name:	2-cyclohexyl-10-phenyl-1,9,10,10a-tetrahydropyrrolo[3,4-b][1,5]benzodiazepin-3(2H)-one
CAS:	7468-51-1
Molecular Formula:	C₂₃H₂₅N₃O
Molecular Weight:	359.4641
InChI:	InChI=1/C23H25N3O/c27-23-22-18(15-26(23)17-11-5-2-6-12-17)21(16-9-3-1-4-10-16)24-19-13-7-8-14-20(19)25-22/h1,3-4,7-10,13-14,17-18,21,24H,2,5-6,11-12,15H2
Molecular Structure:
Properties
Flash Point:	287.5°C
Boiling Point:	551.8°C at 760 mmHg
Density:	1.29g/cm³
Refractive index:	1.695
Flash Point:	287.5°C
Safety Data

Other Product

10-phenyl-3,4,9,10-tetrahydropyrrolo[3,4-b][1,5]benzodiazepin-1(2H)-one
10-(4-methoxyphenyl)-3,4,9,10-tetrahydropyrrolo[3,4-b][1,5]benzodiazepin-1(2H)-one
10-(4-bromophenyl)-3,4,9,10-tetrahydropyrrolo[3,4-b][1,5]benzodiazepin-1(2H)-one
10-(2-hydroxyphenyl)-3,4,9,10-tetrahydropyrrolo[3,4-b][1,5]benzodiazepin-1(2H)-one
10-(3,4-dimethoxyphenyl)-3,4,9,10-tetrahydropyrrolo[3,4-b][1,5]benzodiazepin-1(2H)-one
Pyrrolo[3,4-b][1,5]benzodiazepin-1(2H)-one,3,4,9,10-tetrahydro-10-(4-hydroxy-3-methoxyphenyl)-
N-[9-Amino-4-oxo-1-phenyl-3,4,6,7-tetrahydropyrrolo[3,2,1-jk][1,4]benzodiazepin- 3(R)-yl]pyridine-3-carboxamide
Spiro[furan-3(2H),1'(2'H)-phenanthren]-5(4H)- one,2'-[(1R,2S)-2-(acetyloxy)-1-methyl-3- [(2S,4R)-tetrahydro-4-methyl-5-oxo-2- furanyl]propyl]-3',4',4'a,4'b,5',6',7',8',8'a,9',10',- 10'a-dodecahydro-7'-hydroxy-4'b,8',8',10'atetramethyl-,(1'S,2'R,4'aR,4'bR,7'S,8'aR,- 10'aR)-
Spiro[furan-2(5H),2'-[2H]furo[3,2-c]pyrrolo[1,2-a]azepin]-5-one,1'-ethyl-1',3'a,4',5',6',8',9',10',10'a,10'b-decahydro-4-methyl-8'-[(2R,4R)-tetrahydro-4-methyl-5-oxo-2-furanyl]-,(1'R,2S,3'aS,8'R,10'aR,10'bS)-rel-(-)-
8b-benzyl-2-cyclohexyl-3a-hydroxy-1,3a,4,8b-tetrahydropyrrolo[3,4-b]indol-3(2H)-one
2H-1,4-Benzodiazepin-2-one,7-chloro-1,3- dihydro-1-methyl-5-phenyl-,mixt. with 10-[3-(4-methyl-1-piperazinyl)propyl]-2- (trifluoromethyl)-10H-phenothiazine dihydrochloride and (1R,2S)-rel-2-phenylcyclopropanamine sulfate (2:1)
Pyrrolo(3,4-b)(1,5)benzodiazepin-1(2H)-one, 3,4,9,10-tetrahydro-10-(4-hydroxyphenyl)-
Spiro[phenanthrene-9(1H),5'-[5H]phenanthro[1,- 10-bc]furan]-2',5,6',8,10(2H)-pentone,3,4,4a,- 6'a,7',8',9',10',10a,10'a-decahydro-1',6- dihydroxy-1,1,4a,7',7',10'a-hexamethyl-3',7- bis(1-methylethyl)-,(4S,5'S,6'aS,10aS,10'aS)-
4-(3-chloropropanoyl)-3,3a,4,9-tetrahydropyrrolo[2,1-b]quinazolin-1(2H)-one
Benzo[b]thiophen-3(2H)-one,2-[[4-[(10-bromodecyl)oxy]phenyl]methylene]-5-hexyl-
1/C9H19N/c1-3-9(4-2)10-7-5-6-8-10/h9H,3-8H2,1-2H
1/C11H10O2/c1-9(12)3-4-10-5-7-11(13-2)8-6-10/h5-8H,1-2H
Pyrrolo[3,2-b][1,5]benzodiazepin-10(1H)-one,4,9-dihydro-1,3-dimethyl-4-[1-oxo-3-(1-pyrrolidinyl)propyl]-
Spiro[furan-2(3H),7'-[7H-3]oxacyclopenta[5,6]cycloocta[1,2,3-cd]pentalen]-4'(1'H)-one,2',2'a,4,5,6',6'a,8',9',9'a,10',10'a,10'b-dodecahydro-1',2'a-dihydroxy-1',3,9'a-trimethyl-5-(2-methyl-1-propen-1-yl)-,(1'R,2S,3S,6'aR,9'aR,10'aS,10'bR)-
1/C6H4F3N/c7-3-1-4(8)6(10)5(9)2-3/h1-2H,10H